Cardiac troponin autoantibodies and cancer therapy-related cardiac dysfunction in breast cancer patients receiving anthracycline treatment: secondary analysis of the PRADA study
Cardiac troponin autoantibodies and cancer therapy-related cardiac dysfunction in breast cancer patients receiving anthracycline treatment: secondary analysis of the PRADA study. // Clinica Chimica Acta. – URL: https://www.sciencedirect.com/science/article/pii/S0009898126020759?dgcid=rss_sd_all
Cardiac troponin autoantibodies and cancer therapy-related cardiac dysfunction in breast cancer patients receiving anthracycline treatment: secondary analysis of the PRADA study. Clinica Chimica Acta. https://www.sciencedirect.com/science/article/pii/S0009898126020759?dgcid=rss_sd_all
“Cardiac troponin autoantibodies and cancer therapy-related cardiac dysfunction in breast cancer patients receiving anthracycline treatment: secondary analysis of the PRADA study.” Clinica Chimica Acta.
@article{article40506,
title = {Cardiac troponin autoantibodies and cancer therapy-related cardiac dysfunction in breast cancer patients receiving anthracycline treatment: secondary analysis of the PRADA study},
journal = {Clinica Chimica Acta},
url = {https://www.sciencedirect.com/science/article/pii/S0009898126020759?dgcid=rss_sd_all}
}
ABSTRACT Three‐dimensional (3D) printing enables precise control over scaffold geometry, porosity, material distribution, and spatial delivery of cells and bioactive cues. However, features intended to improve biological fidelity often...